Your browser doesn't support javascript.
loading
Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells.
Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves; Alves-Silva, Antônio Bruno; Fonseca, Natasha Peixoto; Coelho-Silva, Juan Luiz; Scheucher, Priscila Santos; Rego, Eduardo Magalhães; Figueiredo-Pontes, Lorena Lôbo; Machado-Neto, João Agostinho; Traina, Fabiola.
Affiliation
  • Fernandes JC; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Fenerich BA; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Alves-Silva AB; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Fonseca NP; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Coelho-Silva JL; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Scheucher PS; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Rego EM; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao P
  • Figueiredo-Pontes LL; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.
  • Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, SP, Brazil.
  • Traina F; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil. Electronic address: ftraina@fmrp.usp.br.
Toxicol In Vitro ; 83: 105384, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35568132
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloproliferative Disorders / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicol In Vitro Journal subject: TOXICOLOGIA Year: 2022 Document type: Article Affiliation country: Brazil Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloproliferative Disorders / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicol In Vitro Journal subject: TOXICOLOGIA Year: 2022 Document type: Article Affiliation country: Brazil Country of publication: United kingdom